Skip to main content

Table 1 30-day point prevalent abstinence at 6 months and 12 months by treatment group

From: Simultaneous vs. sequential treatment for smoking and weight management in tobacco quitlines: 6 and 12 month outcomes from a randomized trial

  Control N = 840 Sequential N = 849 Simultaneous N = 839 Weight management treatment vs control: Wald’s X2; p-value
6-month outcomes
 % abstinent (Multiply Imputed) 44.9 48.3 40.3 2.94; p = 0.08a
 % abstinent (Missing = Smoking) 24.4 23.8 19.2 7.84; p = 0.02b
12-month outcomes
 % abstinent (Multiply Imputed) 46.0 46.3 40.7 1.83, p = 0.16c
 % abstinent (Missing = Smoking) 28.2 26.9 24.1 3.89, p = 0.14
  1. aThere was a statistically significant difference between the simultaneous and control groups (p = 0.036) and between simultaneous and sequential (p = 0.032).
  2. bThere was a statistically significant difference between the simultaneous and sequential groups (p = 0.024) and between the simultaneous and control groups (p = 0.01).
  3. cSimultaneous group was significantly different from controls (p = 0.039)